By Elias Schisgall
Shares of Azenta plunged after the life sciences company widened its loss and missed Wall Street expectations for adjusted earnings in the fiscal first quarter.
Shares fell 22% to $28.70 in Wednesday morning trading. The stock has fallen 45% in the past 12 months.
Azenta posted a loss of $15.4 million, or 34 cents a share, compared with a loss of $11 million, or 25 cents a share, a year earlier.
On an adjusted basis, the company posted earnings of 9 cents a share, behind Wall Street's expectation of 14 cents a share, according to FactSet.
Revenue rose slightly to $148.6 million, up from $147.4 million a year earlier. Analysts polled by FactSet were expecting $147.1 million in revenue. Adjusted for foreign exchange impacts, organic revenue fell 1% year-over-year, the company said.
Write to Elias Schisgall at elias.schisgall@wsj.com
(END) Dow Jones Newswires
February 04, 2026 10:59 ET (15:59 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.